Development of Anti‐Inflammatory Extracellular Vesicles by Surface Expression of Syndecan‐4
Journal of Extracellular Vesicles · 2026-04 · 15 (4)
DOI: 10.1002/jev2.70266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 02.04.2026. Verfasst von Lijuan Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenbur…. Hauptthemen laut MEDLINE: Syndecan-4, Extracellular Vesicles, Anti-Inflammatory Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Heart-Lung Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
The biological functions of extracellular vesicles (EVs) depend on their cellular source. Further, different subpopulations of EVs from the same cells carry different cargo, but differences in their biological functions are less understood. We here identify a very small EV subpopulation released by HEK293F cells (miniEVs). These EVs, in contrast to the larger EVs, were found to have anti‐inflammatory properties. Quantitative proteomics identified a potential anti‐inflammatory molecule, Syndecan‐4 (SDC4), on the surface of the miniEVs, but not on larger EVs. We engineered HEK293F cells to overexpress SDC4, which results in the molecule being highly expressed in all EV subpopulations. Expression of SDC4, a proteoglycan, also increased the presence of heparan sulfate on the EV surface. Furthermore, these EVs were found to have potent anti‐inflammatory effects in vitro, which heparinase treatment could slightly reduce. Furthermore, the SDC4 EVs showed anti‐inflammatory effects in vivo in a model of peritonitis. We conclude that HEK293F miniEVs convey anti‐inflammatory properties, and SDC4‐expressing HEK293F‐EV potentially could become an anti‐inflammatory therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Krefting Research Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Lab…
ORCID-Profile: Markus Bergqvist, Kyong-Su Park, Cecilia Lässer, Jan Lötvall
Förderung
- Swedish Research Council
- Swedish Heart-Lung Foundation
- National Natural Science Foundation of China
- Vetenskapsrådet
Zitieren
APA
Yu, L., Bergqvist, M., Park, K. S., Lässer, C., & Lötvall, J. (2026). Development of Anti‐Inflammatory Extracellular Vesicles by Surface Expression of Syndecan‐4. Journal of Extracellular Vesicles, 15(4). https://doi.org/10.1002/jev2.70266
Vancouver
Yu L, Bergqvist M, Park KS, Lässer C, Lötvall J. Development of Anti‐Inflammatory Extracellular Vesicles by Surface Expression of Syndecan‐4. Journal of Extracellular Vesicles. 2026;15(4). doi:10.1002/jev2.70266
BibTeX
@article{Yu2026,
author = {Yu, Lijuan and Bergqvist, Markus and Park, Kyong-Su and Lässer, Cecilia and Lötvall, Jan},
title = {Development of Anti‐Inflammatory Extracellular Vesicles by Surface Expression of Syndecan‐4},
journal = {Journal of Extracellular Vesicles},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/jev2.70266}
}
EUVIMED